Full-Time

Applications Scientist

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for drug discovery research

Enterprise Software
Biotechnology
Healthcare

Compensation Overview

$120k - $160kAnnually

Senior

San Diego, CA, USA

Hybrid workweeks expected.

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Python
Requirements
  • PhD in computational chemistry or a related field
  • Post-doctoral research and/or relevant experience in the life-science commercial sector
  • Fluency in both English and Mandarin are required
  • Willingness to work flexible hours, in order to maximize the overlap between US Pacific and China business hours
  • Ability and willingness to travel to China on at least a quarterly basis, or as required
  • A solid understanding of the commercial drug discovery process
  • Experience in one of the following: molecular dynamics simulations/enhanced sampling/free energy calculation methods, ligand-based drug design, quantum mechanics, and/or structural modeling
  • Programming experience (preferably Python) is a plus
  • Medicinal chemistry knowledge is a plus
Responsibilities
  • Provide scientific support to current and prospective life-science customers based in China, which includes demonstrating the optimal use of our life science software suites, facilitating interactions between customers and product development teams, and providing general scientific guidance
  • Engage in cutting edge scientific research to continuously develop personal expertise and establish best practices for customers
  • Work cross-functionally with Product Managers, Account Managers and the Marketing team to improve business strategies
  • Publish scientific papers and present at conferences

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative drug discovery programs, allowing them to work closely with clients on specific projects. The company's goal is to enhance scientific research and innovation by providing powerful tools and resources that support the development of new therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger received a $10M grant to expand predictive toxicology tools.
  • The discovery of SGR-1505 showcases Schrödinger's platform efficiency in drug discovery.
  • Schrödinger's focus on ESG matters enhances corporate reputation and stakeholder trust.

What critics are saying

  • Increased competition from Recursion and Exscientia merger in AI drug discovery.
  • Avicenna's ML-enhanced platform could outpace Schrödinger's capabilities.
  • High cost and complexity of drug discovery could strain Schrödinger's resources.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceutical companies and academic institutions.
  • The company engages in both wholly-owned and collaborative drug discovery programs.
  • Schrödinger's computational tools are used in over 70 countries worldwide.

Help us improve and share your feedback! Did you find this helpful?